TIL Therapy(NeogenTC Corp)

N/A

Report date: 2023/11/06 20:04:57

Base Information

Drug NameTIL Therapy(NeogenTC Corp)

Drug Alias NameTumor-infiltrating lymphocytes(NeogenTC Corp)autologous tumor infiltrating lymphocytes (TILs)(NeogenTC Corp)NEOG-100

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsLung NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNeogenTC Corp

China Registration ClassN/A

Develop Information

Active CompaniesNeogenTC Corp

Inactive CompaniesN/A

Active IndicationsLung NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A